by Growing Trend of Minimally Invasive Cardiac Output Monitoring to Accelerate Market Growth
Technological advancements have enabled continuous real-time cardiac output (CO) monitoring in lithium dilution technique. This technique is projected to witness exponential growth in the cardiac output monitoring devices market during the forecast period. Lithium dilution (LiD) is known to exhibit good correlation with the pulmonary artery catheter (PAC) thermodilution technique in hyperdynamic conditions. This trend has helped manufacturers in the cardiac output monitoring devices market to leverage opportunities in lithium dilution and PAC thermodilution technique. Thus, LiDCOplus technology is being used as a reliable substitute for more invasive PAC thermodilution methods.
Get the sample copy of report@ https://qyresearchmedical.com/sample/111751
The trend of minimally invasive cardiac output monitoring (MICOM) devices is triggering growth for the cardiac output monitoring devices market. Improvements in the cardiac output monitoring devices market landscape has led to innovations in less-invasive Doppler ultrasound.
Rising Adoption of Transthoracic Impedance & Bioreactance Analysis Technology
The cardiac output monitoring devices market is witnessing increasing adoption of less-invasive methods for measuring stroke volume (SV) and CO in patients. Transthoracic electrical bioimpedance (TEB) and Doppler echocardiography (transthoracic echocardiography) are both non-invasive methods used for the measurement of SV and CO. Though invasive devices hold the highest revenue in the cardiac output monitoring devices market, a high number of healthcare providers are opting for non-invasive methods to improve patient life quality.
Get a glimpse of the in-depth analysis through our Report Brochure
TEB is increasingly gaining popularity among healthcare providers to offer continuous estimates on SV, whereas transthoracic echocardiography (TTE) is being used for intermittent image-based estimates. As such, TTE is an important technique in transthoracic impedance & bioreactance analysis. Thus, the transthoracic impedance & bioreactance analysis segment holds a higher value as compared to the Doppler segment in the cardiac output monitoring devices market, with the former expected to reach a value of ~US$ 200 Mn by 2027. This can be attributed to increased adoption of TTE in cardiac functional assessment, especially in critical care. Hence, manufacturers in the cardiac output monitoring devices market are increasing their efficacy to develop advanced devices involving TEB and TTE.
Deep Learning to Help Overcome Limitations of Arterial Waveform Analysis Technique
There is a growing need for innovative methods to assess flow-based hemodynamic parameters, such as SV, in patients. Healthcare providers in the cardiac output monitoring devices market landscape are increasing efforts to assess SV in patients, since SV provides important insights into systemic oxygen delivery and global tissue perfusion.
The arterial waveform analysis technique is gaining importance as a non-invasive and commercially available method to assess SV. As such, the technique is estimated for an exponential growth and this technology segment of the cardiac output monitoring devices market is expected to reach a value of ~US$ 300 Mn by 2027. Insights into this novel technique has enabled healthcare providers operating in the cardiac output monitoring devices market to optimize diagnostic and treatment strategies.
However, several concerns regarding this technique such as the need for manual calibration and unreliable estimation of the hemodynamic profile, act as key restraints for device manufacturers. Hence, healthcare companies in the cardiac monitoring devices market are adopting the technology of deep learning (DL) to overcome the limitations of the arterial waveform analysis technique.
Lithium Dilution and Pulse Contour CO Gain Popularity as Non-invasive Treatment Methods
Cardiac output (CO) is a vital physiological surrogate parameter, addressing the comprehensive hemodynamic profile of patients. Moreover, healthcare providers in the cardiac output monitoring devices market landscape are diversifying the application of CO measurement for athletes. This trend is creating incremental opportunities for both healthcare providers as well as companies in the cardiac monitoring devices market.
Catheter-based measuring is a clinically-approved standard for CO measurement. As such, PAC is estimated to account for the highest revenue amongst all technologies in the cardiac output monitoring devices market. The segment is projected to reach a value of ~US$ 600 Mn by 2027. However, catheter-based measuring is an invasive method, which is associated with high risks of morbidity and mortality in patients.
Additionally, the use of PAC is restricted only to certain medical procedures. Hence, manufacturers in the cardiac output monitoring devices market are increasing production capabilities of consumables and devices for lithium dilution technique and thermodilution pulse contour analysis. Growing awareness about non-invasive methods among patients has accelerated the growth of the two segments.
Analysts’ Viewpoint
Machine learning-based SV estimation is creating incremental opportunities for companies in the cardiac output monitoring devices market. Companies should tap into opportunities in CO measurement for maternal hemodynamic function. Emergence of non-invasive techniques has catalyzed the demand for CO monitoring in pregnant women.
Though transthoracic impedance & bioreactance analysis technology segment holds a significant share of the cardiac output monitoring devices market, the technique is restricted for use in only certain medical procedures and is associated with inaccurate cardiac output estimations. Hence, manufacturers should increase their focus on Doppler echocardiography to help healthcare companies offer better outcomes in patients. Companies should increase efficacy in MICOM devices and increase availability of goal-directed treatment options.
Cardiac Output Monitoring Devices Market: Overview
This report analyzes the current scenario and future prospects of the global cardiac output monitoring devices market. Rise in prevalence of cardiovascular diseases across the globe and increase in geriatric patient pool are the key factors projected to drive the global cardiac monitoring devices market during the forecast period.
The report provides an elaborate executive summary, including a snapshot of various segments of the cardiac monitoring devices market. It also provides elaborate information and data analysis of the global cardiac output monitoring devices market with regards to segments based on technology, product, type, end user, and region.
The overview section of the report provides a detailed qualitative analysis of drivers and restraints, and opportunities that impact the global cardiac monitoring devices market
The report includes company profiles, which provide information about their business, product portfolios, and competitive landscape in the cardiac monitoring devices market
The report on the global cardiac output monitoring devices market offers market attractiveness analysis of the regions and segments
The last section of the report comprises quantitative and qualitative analysis on market share/position of key players operating in the global cardiac monitoring devices market. It analyzes the key competitive strategies adopted by major industry players, thereby presenting a thorough understanding of the competitive scenario in the global cardiac monitoring devices market.
Cardiac Output Monitoring Devices Market: Key Segments
In terms of technology, the global cardiac output monitoring devices market has been classified into pulmonary artery catheter, thermodilution pulse contour analysis technique, lithium dilution technique, arterial waveform analysis technique, Doppler, transthoracic impedance & bioreactance analysis, and others. The pulmonary artery catheter segment held a major share of the global cardiac monitoring devices market in 2018 and the trend is anticipated to continue during the forecast period.
Based on product, the global cardiac output monitoring devices market has been segmented into consumables & accessories, and devices. The consumables & accessories segment accounted for majority of the share of the cardiac monitoring devices market in 2018.
Based on type, the global cardiac monitoring devices market has been segmented into invasive and non-invasive. The invasive segment accounted for majority of the share of the cardiac monitoring devices market
In terms of end user, the global cardiac output monitoring devices market has been categorized into hospitals, ambulatory surgical centers, and others
The market value and forecast for each of these segments have been provided from 2017 to 2027. The CAGRs of respective segments have also been provided from 2019 to 2027, considering 2018 as the base year.
Cardiac Output Monitoring Devices Market: Regional Outlook
In terms of region, the global cardiac output monitoring devices market has been segmented into North America (U.S. and Canada), Europe (U.K., Germany, Spain, Italy, France, and Rest of Europe), Asia Pacific (China, India, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (GCC Countries, South Africa, and Rest of Middle East & Africa). Each region considered in the market has been divided into countries/sub-regions.
The cardiac output monitoring devices market report provides value and forecast for each region and country/sub-region from 2017 to 2027. The compound annual growth rates (CAGRs) for each of these regions and countries have also been provided for the forecast period from 2019 to 2027. The cardiac monitoring devices market study also covers the competitive scenario in these regions.
Cardiac Output Monitoring Devices Market: Key Market Players
Key players in the global cardiac output monitoring devices market have been profiled based on attributes such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies
Major companies profiled in the global cardiac monitoring devices market report include
- GE Healthcare
- Getinge AB
- Edward Lifesciences Corporation
- Baxter International Inc.
- LiDCO Group plc
- ICU Medical, Inc.
- Deltex Medical Group plc
- Uscom
- CNSystems Medizintechnik GmbH
- Osypka Medical GmbH
Key Questions Answered in Global Cardiac Output Monitoring Devices Market Report
- What are the major drivers, restraints, and opportunities in the market?
- What are the revenue share projections of key segments of the global cardiac monitoring devices market during the forecast period?
- Which segment is likely to lead the cardiac monitoring devices market in terms of revenue during the forecast period?
- How alliances & partnerships among players are widening the scope for cardiac output monitoring devices?
- What is the market position of different companies operating in the global cardiac output monitoring devices market?
Cardiac Output Monitoring Devices Market – Segmentation
Technology
- Pulmonary Artery Catheter
- Thermodilution Pulse Contour Analysis Technique
- Lithium Dilution Technique
- Arterial Waveform Analysis Technique
- Doppler
- Transthoracic Impedance & Bioreactance Analysis
- Others
Product
- Consumables & Accessories
- Devices
Type
- Invasive
- Non-invasive
End User
- Hospitals
- Ambulatory Surgical Centers
- Others
Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Purchase Complete Report Now@ https://qyresearchmedical.com/report/checkout/111751/2900
